Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dyadic to Present at the 20th Annual B. Riley FBR Investor Conference and Upcoming Industry Events

JUPITER, FL / ACCESSWIRE / May 17, 2019 / Dyadic International, Inc. (the ''Company'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.17 (-7.77%)
Dyadic Reports First Quarter 2019 Financial Results and Recent Developments

Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower...

FSNN : 0.0580 (-19.44%)
DYAI : 6.17 (-7.77%)
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines

PUNE, INDIA and JUPITER, FL / ACCESSWIRE / May 8, 2019 / Dyadic International, Inc. (''Dyadic'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary...

DYAI : 6.17 (-7.77%)
New Gene Therapies Hold Out Promise for Patients

Gene therapies are gaining growing attention within the medical sector.

TROV : 2.53 (-0.78%)
ONCE : 101.91 (-3.01%)
NVS : 92.80 (+0.34%)
DYAI : 6.17 (-7.77%)
Dyadic Announces Sub-Licensing Agreement with Alphazyme

JUPITER, FL / ACCESSWIRE / May 6, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.17 (-7.77%)
Dyadic to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019

JUPITER, FL / ACCESSWIRE / April 25, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.17 (-7.77%)
Dyadic Announces Uplisting to the Nasdaq Capital Market

JUPITER, FL / ACCESSWIRE / April 15, 2019 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.17 (-7.77%)
OTC Company Investor Presentations Now Available for On-Demand Viewing

Virtual Investor Conferences, the leading proprietary investor conference series, announced that the presentations from the April 4th, 2019 conference are now available for on-demand viewing at VirtualInvestorConferences.com....

PYR.VN : 0.540 (unch)
SMID : 8.8000 (unch)
FLY.VN : 1.640 (-2.96%)
AXV.VN : 0.850 (+1.19%)
DYAI : 6.17 (-7.77%)
BFGC : 0.1410 (-3.56%)
WDLF : 0.1321 (+32.10%)
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com April 4th

Dyadic International, Inc. (the "Company") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower...

DYAI : 6.17 (-7.77%)
Live Investor Conference & Webinar April 4th

Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors,...

PYR.VN : 0.540 (unch)
SMID : 8.8000 (unch)
FLY.VN : 1.640 (-2.96%)
AXV.VN : 0.850 (+1.19%)
DYAI : 6.17 (-7.77%)
WDLF : 0.1321 (+32.10%)
BFGC : 0.1410 (-3.56%)
Dyadic Reports 2018 Year End Results and Recent Developments

/ Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development,...

MTZPY : 11.1700 (-0.36%)
FSNN : 0.0580 (-19.44%)
DYAI : 6.17 (-7.77%)
QUOT : 10.63 (+0.76%)
Dyadic International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 27, 2019 / Dyadic International, Inc. (OTCQX: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 27, 2019 at 5:00 PM...

DYAI : 6.17 (-7.77%)
Dyadic to Present at Three Upcoming Investor Conferences

JUPITER, FL / ACCESSWIRE / March 25, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI), today announced that its President and Chief Executive Officer, Mark Emalfarb and Chief Accounting...

DYAI : 6.17 (-7.77%)
Dyadic to Report Year End 2018 Financial Results on Wednesday March 27, 2019

JUPITER, FL / ACCESSWIRE / March 13, 2019 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system...

DYAI : 6.17 (-7.77%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7634 (+1.49%)
TRLFF : 0.3160 (+3.95%)
AITB : 5.16 (-0.77%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.2500 (-3.85%)
ATEA : 6.0000 (+0.84%)
CWBHF : 13.8000 (-6.44%)
CVSI : 4.0000 (-3.78%)
DUOT : 0.7799 (+1.29%)
CRLBF : 11.0400 (-0.09%)
ARREF : 0.5202 (+3.60%)
CLOK : 0.9599 (-0.01%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.2800 (-2.10%)
HEOFF : 0.9341 (-0.42%)
MJARF : 0.9800 (-1.01%)
ALEAF : 0.8138 (-5.37%)
OTCM : 33.5000 (+3.08%)
NUPMF : 1.8988 (+1.54%)
GLDLF : 0.7295 (+6.23%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3299 (-0.03%)
GBPT : 0.3000 (+5.93%)
IMLFF : 0.2700 (-1.78%)
KSHB : 4.4616 (+1.63%)
CORVF : 1.6400 (+2.50%)
ELLXF : 2.7200 (-2.33%)
RSSS : 2.2804 (-0.85%)
ISYRF : 0.9150 (+4.21%)
FLUX : 1.0500 (-4.55%)
NWGI : 0.3010 (-14.73%)
QBIO : 1.4800 (+8.03%)
WIZD : 0.1600 (unch)
MRMD : 2.2100 (unch)
GRWG : 3.0100 (-1.63%)
BRTI : 0.1000 (-25.93%)
GTBP : 0.2700 (+3.85%)
MRIC : 3.1500 (-1.25%)
DYAI : 6.17 (-7.77%)
GTBIF : 10.4561 (-3.09%)
MTAFF : 0.8389 (+4.99%)
EMHTF : 1.8500 (-7.50%)
ITHUF : 3.0012 (-4.12%)
ALYE : 3.5000 (-12.50%)
VTLR : 0.1281 (-2.21%)
ARHH : 1.2600 (unch)
OWCP : 0.0192 (+34.27%)
STLHF : 0.6722 (+11.74%)
PPCB : 0.0068 (-9.33%)
ARTH : 0.2900 (-6.45%)
ACRGF : 19.4115 (+1.63%)
Making Profits, Saving Lives With Gene Therapy

After thirty years of development, gene therapy is seeing a surge of progress and profitability.

TROV : 2.53 (-0.78%)
ONCE : 101.91 (-3.01%)
NVS : 92.80 (+0.34%)
DYAI : 6.17 (-7.77%)
GNPX : 1.32 (-4.35%)
Dyadic International to Present at the 2019 LD Micro Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / March 11, 2019 / Dyadic International (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform...

DYAI : 6.17 (-7.77%)
Dyadic to Present at Two Upcoming Investor Conferences

JUPITER, FL / ACCESSWIRE / February 25, 2019 / Dyadic International, Inc. (the ''Company'') (OTCQX: DYAI), today announced that its President and Chief Executive Officer, Mark Emalfarb, will be presenting...

DYAI : 6.17 (-7.77%)
Dyadic Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the "SEC") has declared the Company's...

DYAI : 6.17 (-7.77%)
Dyadic International Named to 2019 OTCQX Best 50

JUPITER, FL / ACCESSWIRE / January 24, 2019 / Dyadic International, Inc. ("Dyadic" or "the Company") (OTCQX: DYAI) is pleased to announce it has been named to the 2019 OTCQX® Best 50, a ranking of top...

DYAI : 6.17 (-7.77%)

Van Meerten Stock Picks

Cohen & Steers REIT ETF
My Pick of the Day is the Cohen & Steers REIT ETF (ICF).
ICF -0.59
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar